Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$4.28M$4.28Mderived+15.2% vs Q4 2020 Net Income-$4.15M-$4.15MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,194,000— Operating Incomederived-$3,982,000N/M Operating Cash Flowderived-$3,552,000N/M Free Cash Flowderived-$3,590,000— Margins · derivedGross margin74.6%
Operating margin-93.0%−32.1 pt vs Q4 2020
Net margin-96.9%−54.3 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 9, 2022 · 68 d after period end